End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2.36
CNY
|
+4.89%
|
|
+4.42%
|
-40.10%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,160
|
3,466
|
5,937
|
8,421
|
6,453
|
3,006
|
Enterprise Value (EV)
1 |
4,830
|
5,201
|
8,662
|
9,350
|
7,428
|
4,020
|
P/E ratio
|
26.6
x
|
222
x
|
-44.7
x
|
-33.7
x
|
-3.97
x
|
-8.76
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.44
x
|
1.1
x
|
2.99
x
|
5.47
x
|
4.76
x
|
2.2
x
|
EV / Revenue
|
1.67
x
|
1.65
x
|
4.36
x
|
6.08
x
|
5.48
x
|
2.95
x
|
EV / EBITDA
|
16.6
x
|
28.8
x
|
36.5
x
|
-118
x
|
104
x
|
32.8
x
|
EV / FCF
|
-10.6
x
|
-30.9
x
|
-9.14
x
|
3.23
x
|
-113
x
|
11.8
x
|
FCF Yield
|
-9.48%
|
-3.24%
|
-10.9%
|
31%
|
-0.89%
|
8.5%
|
Price to Book
|
2.16
x
|
1.89
x
|
3.46
x
|
5.75
x
|
-39.1
x
|
13.5
x
|
Nbr of stocks (in thousands)
|
783,406
|
782,308
|
781,180
|
781,180
|
781,180
|
762,980
|
Reference price
2 |
5.310
|
4.430
|
7.600
|
10.78
|
8.260
|
3.940
|
Announcement Date
|
3/27/19
|
4/29/20
|
4/28/21
|
4/29/22
|
4/28/23
|
4/10/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,889
|
3,150
|
1,987
|
1,539
|
1,356
|
1,364
|
EBITDA
1 |
290.9
|
180.6
|
237.5
|
-79.54
|
71.64
|
122.5
|
EBIT
1 |
228.7
|
113.3
|
160.2
|
-165.9
|
-35.36
|
6.446
|
Operating Margin
|
7.92%
|
3.6%
|
8.06%
|
-10.78%
|
-2.61%
|
0.47%
|
Earnings before Tax (EBT)
1 |
194.2
|
246.6
|
133.1
|
-224.9
|
-1,554
|
-397.1
|
Net income
1 |
157.3
|
12.09
|
-134.7
|
-253.4
|
-1,583
|
-342.7
|
Net margin
|
5.45%
|
0.38%
|
-6.78%
|
-16.47%
|
-116.76%
|
-25.12%
|
EPS
2 |
0.2000
|
0.0200
|
-0.1700
|
-0.3200
|
-2.080
|
-0.4500
|
Free Cash Flow
1 |
-457.8
|
-168.4
|
-947.8
|
2,898
|
-65.77
|
341.6
|
FCF margin
|
-15.85%
|
-5.34%
|
-47.69%
|
188.33%
|
-4.85%
|
25.04%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
278.81%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/27/19
|
4/29/20
|
4/28/21
|
4/29/22
|
4/28/23
|
4/10/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
670
|
1,736
|
2,725
|
929
|
975
|
1,014
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.302
x
|
9.611
x
|
11.47
x
|
-11.68
x
|
13.62
x
|
8.277
x
|
Free Cash Flow
1 |
-458
|
-168
|
-948
|
2,898
|
-65.8
|
342
|
ROE (net income / shareholders' equity)
|
4.27%
|
4.39%
|
1.44%
|
-11.8%
|
-151%
|
-113%
|
ROA (Net income/ Total Assets)
|
1.32%
|
0.63%
|
1.02%
|
-1.51%
|
-0.55%
|
0.11%
|
Assets
1 |
11,909
|
1,921
|
-13,231
|
16,826
|
286,860
|
-299,554
|
Book Value Per Share
2 |
2.460
|
2.340
|
2.190
|
1.880
|
-0.2100
|
0.2900
|
Cash Flow per Share
2 |
2.270
|
0.8000
|
0.6100
|
0.7700
|
0.3100
|
0.2000
|
Capex
1 |
541
|
561
|
573
|
171
|
51.1
|
22.7
|
Capex / Sales
|
18.72%
|
17.81%
|
28.83%
|
11.1%
|
3.77%
|
1.66%
|
Announcement Date
|
3/27/19
|
4/29/20
|
4/28/21
|
4/29/22
|
4/28/23
|
4/10/24
|
|
1st Jan change
|
Capi.
|
---|
| -40.10% | 248M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|